News

Dan Myers Named Director of Virginia SBDC, Innovation Commercialization Assistance Program to Accelerate Tech-Driven Growth in the Commonwealth

The Virginia Small Business Development Center (SBDC) is pleased to announce that Dan Myers has been named the new Director for the Virginia SBDC – Innovation Commercialization Assistance Program (ICAP).

Dan, a seasoned innovation strategist, will lead the Virginia SBDC – ICAP program that is designed to help Virginia small businesses turn ideas into commercial success. In his new role, Dan will lead the program efforts to support Virginia based innovators and entrepreneurs in bringing high potential technologies and innovations to market, strengthening the state’s innovation ecosystem and advancing economic growth.

With years of experience in innovation management, technology transfer, and startup acceleration, Dan brings a proven track record of guiding early-stage technologies from concept to commercialization. Prior to this new role, he served as a Virginia SBDC – ICAP mentor. Dan will now oversee the program team, develop strategic partnerships, and expand outreach to innovation communities across Virginia.

“Virginia is at a critical inflection point in building a vibrant innovation economy,” said Jody Keenan, State Director of the Virginia SBDC Network. “With Dan on board, we’re committed to move ideas off the bench and into real businesses that create jobs and add value here in the Commonwealth.”

“We live in a moment where Virginia’s entrepreneurial talent, research institutions, and industry partners are aligning,” said Dan Myers. “My priority is to remove friction from the path of innovation so that bright ideas become meaningfully impactful businesses and challenges in the world find built solutions. That means working hand in hand with entrepreneurs, universities, and ecosystem partners in order to see early-stage tech startups, biotech & bioscience companies, and other scalable businesses thrive in Virginia.”

Recent News

11/10/2026

Luminoah Raises $25 Million Series B to Expand Access to Its FDA-Cleared Enteral Feeding System

Luminoah, a medical technology company modernizing enteral nutrition, today announced a $25 million Series B financing led by Sandbox Clinical Ventures, with participation from the Blue Venture Fund, GV (Google Ventures), Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund, the American Gastroenterological Association GI Opportunity Fund, and existing investors. The Series …

11/04/2026

$6 Million in Philanthropic Gifts Establishes UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund. This fund will provide long-term support for the UVA SPARK Innovative Medicines program, helping accelerate promising discoveries toward new treatments and cures. “The mission of the UVA Manning Institute of …

10/29/2026

ReAlta Life Sciences Launches KnowHIE, a New Online Educational Resource for Families of Babies Diagnosed with Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the launch of KnowHIE.com, a new educational website designed to help families and caregivers better understand neonatal hypoxic ischemic encephalopathy (HIE) …